Compile Data Set for Download or QSAR
Report error Found 129 Enz. Inhib. hit(s) with all data for entry = 11820
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650862(US20240043440, Example 58B)
Affinity DataIC50: 0.130nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650874(US20240043440, Example 64A)
Affinity DataIC50: 0.360nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650800(US20240043440, Example 16 | US20240043440, Example...)
Affinity DataIC50: 0.400nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (5 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650868(US20240043440, Example 61A)
Affinity DataIC50: 0.440nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650855(US20240043440, Example 54A)
Affinity DataIC50: 0.450nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650883(US20240043440, Example 68A)
Affinity DataIC50: 0.480nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650865(US20240043440, Example 60A)
Affinity DataIC50: 0.5nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650881(US20240043440, Example 67A)
Affinity DataIC50: 0.520nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650892(US20240043440, Example 74A)
Affinity DataIC50: 0.520nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650861(US20240043440, Example 58A)
Affinity DataIC50: 0.550nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650871(US20240043440, Example 62A)
Affinity DataIC50: 0.560nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650908(US20240043440, Example 86A)
Affinity DataIC50: 0.560nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650847(US20240043440, Example 50A)
Affinity DataIC50: 0.570nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650834(US20240043440, Example 43A)
Affinity DataIC50: 0.580nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650832(US20240043440, Example 42B)
Affinity DataIC50: 0.590nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650877(US20240043440, Example 65A)
Affinity DataIC50: 0.590nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650841(US20240043440, Example 47A)
Affinity DataIC50: 0.650nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650838(US20240043440, Example 46A)
Affinity DataIC50: 0.700nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650826(US20240043440, Example 39A)
Affinity DataIC50: 0.720nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650843(US20240043440, Example 48A)
Affinity DataIC50: 0.720nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650829(US20240043440, Example 41A)
Affinity DataIC50: 0.730nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650852(US20240043440, Example 52A)
Affinity DataIC50: 0.75nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650796(US20240043440, Example 12 | US20240043440, Example...)
Affinity DataIC50: 0.760nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (5 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650823(US20240043440, Example 38A)
Affinity DataIC50: 0.760nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650901(US20240043440, Example 81)
Affinity DataIC50: 0.760nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650911(US20240043440, Example 89A)
Affinity DataIC50: 0.770nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650854(US20240043440, Example 54)
Affinity DataIC50: 0.820nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650886(US20240043440, Example 70)
Affinity DataIC50: 0.880nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650863(US20240043440, Example 59)
Affinity DataIC50: 0.910nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650888(US20240043440, Example 72)
Affinity DataIC50: 0.930nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650887(US20240043440, Example 71)
Affinity DataIC50: 0.980nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650849(US20240043440, Example 51)
Affinity DataIC50: 1nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650857(US20240043440, Example 55)
Affinity DataIC50: 1nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650889(US20240043440, Example 73)
Affinity DataIC50: 1nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650897(US20240043440, Example 78-A)
Affinity DataIC50: 1nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650899(US20240043440, Example 79-A)
Affinity DataIC50: 1nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650902(US20240043440, Example 82)
Affinity DataIC50: 1nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650833(US20240043440, Example 43)
Affinity DataIC50: 1.10nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650840(US20240043440, Example 47)
Affinity DataIC50: 1.10nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650859(US20240043440, Example 57)
Affinity DataIC50: 1.10nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650867(US20240043440, Example 61)
Affinity DataIC50: 1.10nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650876(US20240043440, Example 65)
Affinity DataIC50: 1.10nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650880(US20240043440, Example 67)
Affinity DataIC50: 1.10nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650885(US20240043440, Example 69)
Affinity DataIC50: 1.10nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650906(US20240043440, Example 86)
Affinity DataIC50: 1.10nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650825(US20240043440, Example 39)
Affinity DataIC50: 1.20nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650850(US20240043440, Example 52)
Affinity DataIC50: 1.20nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650860(US20240043440, Example 58)
Affinity DataIC50: 1.20nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650890(US20240043440, Example 74)
Affinity DataIC50: 1.20nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Case Western Reserve University

US Patent
LigandPNGBDBM650904(US20240043440, Example 84)
Affinity DataIC50: 1.20nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 129 total ) | Next | Last >>
Jump to: